ArticleJournal of experimental orthopaedics2025
Similar graft rerupture rates after ACL reconstruction with or without lateral extra-articular procedure in patients over 40 years.
Article in Journal of experimental orthopaedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Similar graft rerupture rates after ACL reconstruction with or without lateral extra-articular procedure in patients over 40 years.Journal of experimental orthopaedics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To compare the outcomes of isolated anterior cruciate ligament reconstruction (ACLR) versus ACLR+ lateral extra articular procedures (LEAP) at midterm follow up in patients older than 40 years old. Methods: This was a retrospective cohort study based on prospectively collected data of patients aged over 40 years who underwent ACLR, with or without LEAP, from 2012 to 2022. Patients were matched by age, sex, preinjury Tegner score, and follow-up duration to minimize selection bias. LEAP was reserved for higher-risk individuals-specifically those with high pivot shift, valgus alignment, recurvatum, chronic lesions, suturable meniscal tears, or high activity levels. The primary outcome was graft rerupture rate, defined as the recurrence of subjective instability associated with abnormal anterior laxity on clinical examination (Lachman grade ≥2 and/or pivot shift grade ≥2) and confirmed by magnetic resonance imaging or intraoperative findings. Secondary outcomes included return-to-sport (RTS) rates, time to RTS, and functional scores, including the International Knee Documentation Committee (IKDC) score, Knee injury and Osteoarthritis Outcome Score (KOOS), Anterior Cruciate Ligament-Return to Sport after Injury (ACL-RSI) score, Lysholm score, and Tegner Activity Scale (TAS). Results: A total of 216 patients were analyzed (142 ACLR, 74 ACLR + LEAP) at a mean follow-up of 59.6 versus 64.5 months respectively ( Conclusion: No significant reduction in overall graft rerupture risk was observed with the addition of LEAP to ACLR in patients over 40 years old. Functional outcomes and reoperation rates were comparable between groups. Study Design: Cohort study, level of evidence 3. Level of Evidence: Level III, cohort study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.